User: Guest  Login
Title:

Should belatacept be the centrepiece of renal transplantation?

Document type:
Journal Article; Review; Review
Author(s):
Huber, Monika; Kemmner, Stephan; Renders, Lutz; Heemann, Uwe
Abstract:
Belatacept was developed to minimize cardiovascular risk and nephrotoxicity associated with calcineurin inhibitor (CNI)-based immunosuppression. Recently, 7-year data from the Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT), a phase III study comparing belatacept with cyclosporine, have been published. While during the first year of belatacept the risk of acute rejection episodes was elevated, this seemingly had marginal consequences for lon...     »
Journal title abbreviation:
Nephrol Dial Transplant
Year:
2016
Journal volume:
31
Journal issue:
12
Pages contribution:
1995-2002
Language:
eng
Fulltext / DOI:
doi:10.1093/ndt/gfw226
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/27288461
Print-ISSN:
0931-0509
TUM Institution:
Fachgebiet Nephrologie (Prof. Heemann)
 BibTeX